摘要 |
<p>A method of judging leukemia, pre-leukemia or an aleukemic malignant blood disease characterized by comprising quantifying stem cell growth factor (SCGF); a method of discriminating leukemia from pre-leukemia or an aleukemic malignant blood disease; a method of discriminating aplastic anemia from myelodysplastic syndrome; a method of judging delayed take in hematopoietic stem cells after transplantation of the hematopoietic stem cells; and a method of judging graft versus host disease. It is also possible to provide a diagnostic for leukemia, pre-leukemia or an aleukemic malignant blood disease and a diagnostic for delayed take in hematopoietic stem cells after transplantation of the hematopoietic stem cells or graft versus host disease (GVHD) each containing as the active ingredient an antibody reacting with stem cell growth factor (SCGF).</p> |